Inhibikase Therapeutics, Inc.IKTNASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
-5.88%
↑ 96% vs avg
Percentile
P63
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-137.81%
Historical baseline
| Period | Value |
|---|---|
| 2024 | -5.88% |
| 2023 | -4.23% |
| 2022 | -21.36% |
| 2021 | -1165.95% |
| 2020 | -233.84% |
| 2019 | -147.31% |
| 2018 | 665.69% |
| 2017 | -327.39% |
| 2016 | 0.00% |